These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 34370344)

  • 1. Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single centre.
    Akdaş E; Öğüt B; Erdem Ö; Öztaş MO; İlter N
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e861-e864. PubMed ID: 34370344
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers.
    Bayhan GI; Guner R
    Hum Vaccin Immunother; 2022 Dec; 18(1):2020017. PubMed ID: 35172694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
    Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
    Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine.
    Yavuz E; Günal Ö; Başbulut E; Şen A
    J Med Virol; 2022 Aug; 94(8):3768-3775. PubMed ID: 35434796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibody titers elicited by CoronaVac and BNT162b2 vaccines in health care workers with and without prior SARS-CoV-2 infection.
    Wolff MJ; Acevedo ML; Núñez MA; Lafourcade M; Gaete-Argel A; Soto-Rifo R; Valiente-Echeverría F
    J Travel Med; 2022 May; 29(3):. PubMed ID: 35134229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: a prospective cohort study in healthcare workers.
    Rerknimitr P; Puaratanaarunkon T; Wongtada C; Wittayabusarakam N; Krithin S; Paitoonpong L; Kumtornrut C; Kerr SJ; Asawanonda P; Jantarabenjakul W; Klaewsongkram J
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e158-e161. PubMed ID: 34661934
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors Affecting Side Effects, Seroconversion Rates and Antibody Response After Inactivated SARS-CoV-2 Vaccination in Healthcare Workers].
    Şenol Akar Ş; Akçalı S; Özkaya Y; Gezginci FM; Cengiz Özyurt B; Deniz G; Karadağ Yalçın F; Özer D; Dündar Erbay P; Eser E
    Mikrobiyol Bul; 2021 Oct; 55(4):519-538. PubMed ID: 34666653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
    Garvey MI; Wilkinson MAC; Holden E; Shields A; Robertson A; Richter A; Ball S
    J Infect; 2021 Jul; 83(1):119-145. PubMed ID: 33933530
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing humoral immune response after two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthcare workers.
    Demirbakan H; Koçer I; Erdoğan M; Bayram A
    Public Health; 2022 Apr; 205():1-5. PubMed ID: 35219127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between the Effectiveness and Immunogenicity of Inactivated SARS-CoV2 Vaccine (CoronaVac) with the Presence of Hypertension among Health Care Workers.
    Rifai A; Wahono CS; Pratama MZ; Handono K; Susianti H; Iskandar A; Diyah N; Santoningsih D; Samsu N; Gunawan A
    Clin Exp Hypertens; 2022 Apr; 44(3):233-239. PubMed ID: 34994256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic and cutaneous reactions following inactivated SARS-CoV-2 vaccine (CoronaVac
    Durmaz K; Aykut Temiz S; Metin Z; Dursun R; Abdelmaksoud A
    Clin Exp Dermatol; 2022 Jan; 47(1):171-173. PubMed ID: 34415637
    [No Abstract]   [Full Text] [Related]  

  • 13. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience.
    Yigit M; Ozkaya-Parlakay A; Cosgun Y; Ince YE; Bulut YE; Senel E
    J Med Virol; 2022 Jan; 94(1):287-290. PubMed ID: 34487373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers.
    Benjamanukul S; Traiyan S; Yorsaeng R; Vichaiwattana P; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
    J Med Virol; 2022 Apr; 94(4):1442-1449. PubMed ID: 34783049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Surveillance of Healthcare Workers during the SARS-CoV-2 Vaccination Period: An Updated Protocol Suggestion.
    Tovani-Palone MR; Siddiqui MF
    Clinics (Sao Paulo); 2021; 76():e3096. PubMed ID: 34190857
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines.
    Zhang R; Leung KY; Liu D; Fan Y; Lu L; Chan PC; To KK; Chen H; Yuen KY; Chan KH; Hung IF
    mSphere; 2022 Apr; 7(2):e0091521. PubMed ID: 35285250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers.
    Soysal A; Gönüllü E; Karabayır N; Alan S; Atıcı S; Yıldız İ; Engin H; Çivilibal M; Karaböcüoğlu M
    Hum Vaccin Immunother; 2021 Nov; 17(11):3876-3880. PubMed ID: 34324409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
    Baj A; Novazzi F; Genoni A; Ferrante FD; Taborelli S; Pini B; Partenope M; Valli M; Gasperina DD; Capuano R; Prestia M; Spezia PG; Azzi L; Focosi D; Maggi F
    Emerg Microbes Infect; 2021 Dec; 10(1):1254-1256. PubMed ID: 34110974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi GL; Lippi G
    J Infect; 2021 Aug; 83(2):e4-e5. PubMed ID: 34214516
    [No Abstract]   [Full Text] [Related]  

  • 20. Symptomatic post-vaccination SARS-CoV-2 infections in healthcare workers- A multicenter cohort study.
    Vaishya R; Sibal A; Malani A; Kar S; Prasad K H; Sv K; Reddy S; Kamineni S; Reddy S; Reddy P; Chandra Reddy P
    Diabetes Metab Syndr; 2021; 15(6):102306. PubMed ID: 34619430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.